Skip to main content
. 2023 Feb 8;32(1):25–45. doi: 10.7570/jomes22067

Figure 1.

Figure 1

Pancreatic and exopancreatic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide‐1 (GLP-1). *Evidence from preclinical studies.